Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel.
- 23 July 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (14) , 1691-1696
- https://doi.org/10.1016/0960-894x(96)00299-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.Bioorganic & Medicinal Chemistry Letters, 1995
- Agents Combining Thromboxane Receptor Antagonism with Thromboxane Synthase Inhibition: [[[2-(1H-Imidazol-1-yl)ethylidene]amino]oxy]alkanoic AcidsJournal of Medicinal Chemistry, 1994
- A Proposed Common Spatial Pharmacophore and the Corresponding Active Conformations of Some TxA2 Receptor AntagonistsJournal of Chemical Information and Computer Sciences, 1994
- Recent progress in the clinical development of thromboxane A2receptor antagonistsExpert Opinion on Investigational Drugs, 1994
- Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptorsBioorganic & Medicinal Chemistry Letters, 1991
- Thromboxane A2 receptor antagonistsMedicinal Research Reviews, 1991
- Computer-aided molecular modeling of a thromboxane receptor antagonist S-145 and its related compoundsJournal of Medicinal Chemistry, 1990
- Selective thromboxane synthetase inhibitors. 2. 3-(1H-Imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogs.Journal of Medicinal Chemistry, 1986
- The biochemical pharmacology of thromboxane synthase inhibition in man.Circulation, 1985
- The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.Circulation, 1983